Overview
Both Alström and Usher Syndrome cause progressive hearing and vision loss, and both can lead to deafblindness in adulthood. That's where the similarity ends. The genetics, the timing, and the systems involved are very different. This article explains how to tell them apart and why it matters for care.
Why these two conditions get compared
Alström and Usher are both inherited causes of dual sensory loss. Usher Syndrome is the most common genetic cause of combined hearing and vision loss, affecting approximately 1 in 25,000 people. Alström is much rarer, at around 1 in 1,000,000.¹ ² Despite the difference in prevalence, families and even some clinicians group them together because the deafblindness outcome looks similar at a distance.
Up close, they differ in almost every dimension that matters for care.
At a glance
Feature
Causative genes
Alström Syndrome
One gene: ALMS1
Usher Syndrome
Multiple genes (MYO7A, USH2A, CDH23, etc.) — Type 1, 2, and 3
Feature
Inheritance
Alström Syndrome
Autosomal recessive
Usher Syndrome
Autosomal recessive
Feature
Hearing loss timing
Alström Syndrome
Begins in first decade
Usher Syndrome
Type 1: present at birth; Type 2: childhood; Type 3: progressive in adulthood
Feature
Hearing loss type
Alström Syndrome
Sensorineural
Usher Syndrome
Sensorineural
Feature
Vision loss type
Alström Syndrome
Cone-rod dystrophy with severe early photophobia
Usher Syndrome
Retinitis pigmentosa (rod-cone) — night blindness first
Feature
Vision loss timing
Alström Syndrome
Severe by teens, often blind by 20s
Usher Syndrome
Variable — often legally blind by 30s–40s
Feature
Cardiomyopathy
Alström Syndrome
Common (>60% of children)
Usher Syndrome
Not a feature
Feature
Obesity
Alström Syndrome
Almost universal, starting in infancy
Usher Syndrome
Not a feature
Feature
Type 2 diabetes
Alström Syndrome
Near-universal by adolescence/adulthood
Usher Syndrome
Not a feature
Feature
Liver and kidney involvement
Alström Syndrome
Common
Usher Syndrome
Not a feature
Feature
Vestibular dysfunction (balance)
Alström Syndrome
Some reports, generally mild
Usher Syndrome
Type 1: severe (no vestibular function); Type 2: typically normal
Feature
Intellectual function
Alström Syndrome
Typical range
Usher Syndrome
Typical range
| Feature | Alström Syndrome | Usher Syndrome |
|---|---|---|
| Causative genes | One gene: ALMS1 | Multiple genes (MYO7A, USH2A, CDH23, etc.) — Type 1, 2, and 3 |
| Inheritance | Autosomal recessive | Autosomal recessive |
| Hearing loss timing | Begins in first decade | Type 1: present at birth; Type 2: childhood; Type 3: progressive in adulthood |
| Hearing loss type | Sensorineural | Sensorineural |
| Vision loss type | Cone-rod dystrophy with severe early photophobia | Retinitis pigmentosa (rod-cone) — night blindness first |
| Vision loss timing | Severe by teens, often blind by 20s | Variable — often legally blind by 30s–40s |
| Cardiomyopathy | Common (>60% of children) | Not a feature |
| Obesity | Almost universal, starting in infancy | Not a feature |
| Type 2 diabetes | Near-universal by adolescence/adulthood | Not a feature |
| Liver and kidney involvement | Common | Not a feature |
| Vestibular dysfunction (balance) | Some reports, generally mild | Type 1: severe (no vestibular function); Type 2: typically normal |
| Intellectual function | Typical range | Typical range |
Where the conditions meaningfully diverge
Pattern of vision loss
In Alström, cone photoreceptors fail first, which produces severe early photophobia, nystagmus in infancy, and difficulty seeing in bright light. Rod function is initially preserved, so children can see relatively well in dim conditions before declining.³
In Usher, rod photoreceptors fail first (the classic retinitis pigmentosa pattern), which produces night blindness and progressive narrowing of the visual fields. Photophobia is not an early feature.⁴
This difference is often visible on the electroretinogram (ERG) by age 1–2 and is one of the most important early clues to differentiate the two.
Pattern of hearing loss
In Alström, hearing is normal at birth and at the early newborn screening. Hearing loss typically appears in the first decade and progresses over life.
In Usher Type 1, profound hearing loss is present at birth and detected by newborn hearing screening. In Usher Type 2, hearing loss is moderate-to-severe but congenital — also detected on newborn screening in most cases. In Usher Type 3, hearing is normal in early life and declines over time.⁵
A child who fails newborn hearing screening is more likely to have Usher than Alström. A child who passes newborn screening and then develops hearing loss is more likely to have Alström or Usher Type 3 (rare).
Vestibular function
Children with Usher Type 1 have congenital absence of vestibular (balance) function — they typically don't develop independent walking until later, are unsteady on uneven surfaces, and need extra support for swimming. This is a powerful clinical clue. Vestibular function in Alström is usually relatively preserved.⁶
Heart and metabolic systems
This is the most decisive difference. Usher Syndrome does not cause cardiomyopathy, severe insulin resistance, type 2 diabetes, fatty liver, or kidney disease. Alström does — every one of those.
A child labeled with Usher Syndrome who has unexplained heart failure, severe early childhood weight gain, or early diabetes does not fit the Usher pattern, and ALMS1 testing is appropriate.
When the labels get switched
Several patterns lead to a misdiagnosis:
- A baby with Alström who failed an early eye exam and an audiology test (perhaps from the eye signs and hearing concerns) may be labeled Usher Type 2. The systemic features only emerge later.
- An older child or adult with progressive vision loss attributed to retinitis pigmentosa, plus separately diagnosed hearing loss, may carry an Usher label even when ALMS1 hasn't been tested.
When in doubt, a comprehensive deafblindness genetic panel that includes both Usher genes and ALMS1 will resolve the diagnosis.⁷
Why the difference changes care
Surveillance and screening
Alström care includes routine echocardiograms, fasting glucose and lipid panels, kidney and liver studies, and sleep studies — none of these are part of standard Usher care.
Communication planning
Both conditions warrant early Braille and assistive technology training. Both warrant teaching mobility skills with a white cane or guide dog. The pace of decline differs — Usher tends to progress more slowly than Alström, and planning timelines reflect that.
Family planning
Both are autosomal recessive with a 25% recurrence risk in subsequent pregnancies, but the gene panels and carrier testing are different. Genetic counseling is essential for both conditions.
Adult care
Adult-onset complications differ markedly. Adults with Alström typically need cardiology, endocrinology, hepatology, and nephrology in addition to ophthalmology and audiology. Adults with Usher generally need only ophthalmology and audiology along with deafblind support services.
Common questions
Frequently asked questions
Short answers grounded in the article and the underlying references, so families can quickly understand the main point without losing the medical meaning.
Question
Is Alström a type of Usher Syndrome?
Answer
No — Alström is a separate condition with its own gene (ALMS1) and its own pattern of features. They share the deafblindness outcome but are otherwise distinct.
Question
My child has been diagnosed with Usher but also has cardiomyopathy. Should we test for Alström?
Answer
Yes. Cardiomyopathy is not a feature of Usher Syndrome. The combination of progressive hearing and vision loss with cardiomyopathy points strongly to Alström, and ALMS1 genetic testing is appropriate.
Question
Which condition is more common?
Answer
Usher Syndrome is much more common — about 1 in 25,000 — while Alström affects roughly 1 in 1,000,000. That's one reason Usher is usually the first diagnosis considered when a child has both vision and hearing loss.
Question
Can a baby be tested for both at once?
Answer
Yes. Comprehensive deafblindness panels cover both Usher genes and ALMS1, and a single test can rule out or confirm either condition. Ask your genetics team about a broad panel rather than ordering each test separately.